| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| N-Acetyl Cysteine | Cystic Fibrosis | 6 | PM | 35215328 | 📋 | N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review |
| N-Acetyl Cysteine | Cystic Fibrosis | 5 | PM | 34680757 | 📋 | Effect of N-Acetylcysteine in Combination with Antibiotics on the Biofilms of Three Cystic Fibrosis Pathogens of Emerging Importance |
| N-Acetyl Cysteine | Cystic Fibrosis | 4 | PM | 27492531 | 📋 | The Effect of N-acetylcysteine on Biofilms: Implications for the Treatment of Respiratory Tract Infections |
| N-Acetyl Cysteine | Cystic Fibrosis | 3 | PM | 25458464 | 📋 | The Effect of Short-Term, High-Dose Oral N-acetylcysteine Treatment on Oxidative Stress Markers in Cystic Fibrosis Patients With Chronic P. Aeruginosa Infection -- A Pilot Study |
| N-Acetyl Cysteine | Cystic Fibrosis | 2 | PM | 16537378 | 📋 | High-dose Oral N-acetylcysteine, a Glutathione Prodrug, Modulates Inflammation in Cystic Fibrosis |
| N-Acetyl Cysteine | Cystic Fibrosis | 1 | PM | 15281093 | 📋 | N-acetylcysteine Inhibits Na+ Absorption Across Human Nasal Epithelial Cells |
| N-Acetyl Cysteine | Hepatic Fibrosis | 2 | PM | 32791144 | 📋 | Antifibrotic effect of curcumin, n-acetyl cysteine and propolis against bisphenol A-induced hepatotoxicity in rats: Prophylaxis versus co-treatment |
| N-Acetyl Cysteine | Hepatic Fibrosis | 1 | PM | 32655795 | 📋 | Co-administration of everolimus and N-acetylcysteine attenuates hepatic stellate cell activation and hepatic fibrosis |
| N-Acetyl Cysteine | Kidney Fibrosis | 1 | PM | 33268712 | 📋 | Effect of N-Acetyl Cysteine on Renal Interstitial Fibrosis in Mice |
| N-Acetyl Cysteine | Oral Submucous Fibrosis | 1 | PM | 32856877 | 📋 | The Protective Effect of Antioxidants in Areca Nut Extract-Induced Oral Carcinogenesis |
| N-Acetyl Cysteine | Pulmonary Fibrosis | 9 | PM | 36873280 | 📋 | N-Acetylcysteine attenuated pulmonary fibrosis induced by bleomycin via immunomodulation responses |
| N-Acetyl Cysteine | Pulmonary Fibrosis | 8 | PM | 35856379 | 📋 | N-acetylcysteine as a therapeutic approach to post-COVID-19 pulmonary fibrosis adjunctive treatment |
| N-Acetyl Cysteine | Pulmonary Fibrosis | 7 | PM | 35657279 | 📋 | N-Acetylcysteine decreases lung inflammation and fibrosis by modulating ROS and Nrf2 in mice model exposed to particulate matter |
| N-Acetyl Cysteine | Pulmonary Fibrosis | 5 | PM | 34479474 | 📋 | The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis |
| N-Acetyl Cysteine | Pulmonary Fibrosis | 6 | PM | 33720480 | 📋 | Silica dust exposure induces pulmonary fibrosis through autophagy signaling |
| N-Acetyl Cysteine | Pulmonary Fibrosis | 4 | PM | 32658336 | 📋 | Modulation of Bleomycin-induced oxidative stress and pulmonary fibrosis by N-acetylcysteine in Ratsvia AMPK/SIRT1/ NF-Kβ |
| N-Acetyl Cysteine | Pulmonary Fibrosis | 3 | PM | 32440328 | 📋 | Beneficial Effects of N-acetylcysteine on Protease-Antiprotease Balance in Attenuating Bleomycin-Induced Pulmonary Fibrosis in Rats |
| N-Acetyl Cysteine | Pulmonary Fibrosis | 1 | PM | 31273057 | 📋 | N-acetylcysteine Tiherapeutically Protects Against Pulmonary Fibrosis in a Mouse Model of Silicosis |
| N-Acetyl Cysteine | Pulmonary Fibrosis | 2 | PM | 31258714 | 📋 | Efficacy and Safety of N-acetylcysteine Therapy for Idiopathic Pulmonary Fibrosis: An Updated Systematic Review and Meta-Analysis |
